Clinical Trial: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis (EASE)
Brief Summary:
This Phase 2a trial will evaluate the effects of EP262 in subjects with atopic dermatitis
Read more